LAMA2 and muscular dystrophy: Therefore, screening for LAMA2 point mutations, followed by analysis of LAMA2 CNVs, especially exon 4 deletion, may be appropriate as an initial strategy for patients with features consistent with congenital muscular dystrophy, such as muscular dystrophy combined with white matter changes in brain MRI.